至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Biochemical autoregulatory gene therapy for focal epilepsy.

Nat. Med.. 2018-09; 
LiebAndreas,QiuYichen,DixonChristine L,HellerJanosch P,WalkerMatthew C,SchorgeStephanie,KullmannDimit
Products/Services Used Details Operation
Gene Synthesis … Wild-type GluCl (GluCl α subunit, accession number G5EBR3; β subunit, accession number Q17328) including mutation RSR → AAA in the endoplasmic reticulum–retention motif16 was fully codon optimized for human expression and synthesized by Genscript … Get A Quote

摘要

Despite the introduction of more than one dozen new antiepileptic drugs in the past 20 years, approximately one-third of people who develop epilepsy continue to have seizures on mono- or polytherapy. Viral-vector-mediated gene transfer offers the opportunity to design a rational treatment that builds on mechanistic understanding of seizure generation and that can be targeted to specific neuronal populations in epileptogenic foci. Several such strategies have shown encouraging results in different animal models, although clinical translation is limited by possible effects on circuits underlying cognitive, mnemonic, sensory or motor function. Here, we describe an autoregulatory antiepileptic gene therap... More

关键词